Novel Developments in Stem Cell Mobilization: Focus on CXCR4 - Image 1

£108.62

Springer Novel Developments in Stem Cell Mobilization: Focus on CXCR4

Name: Novel Developments in Stem Cell Mobilization: Focus on CXCR4
Brand: Springer
Price: 108.45 GBP
Availability: InStock

Oncology

Price History & Forecast

Last 71 days • 71 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 71 days • 1 price levels

Days at Price

Price Analysis

Most common price: £109 (71 days, 100.0%)

Price range: £109 - £109

Price levels: 1 different prices over 71 days

Description

Product Description Recently the CXCR4/CXCL12-axis has been recognized as one of the pivotal adhesion pathways by which hematopoietic stem cells are retained in the bone marrow. CXCR4 antagonists with different chemical specification are being developed. Pharmacology research guides the way to the rational development effective antagonists. One antagonist, plerixafor, is clinically approved now for stem cell mobilization of lymphoma and myeloma patients. This allows patients to receive potentially life-saving treatment which could not have been administered otherwise. Through early clinical studies it was recognized that CXCR4 antagonists also mobilize malignant hematopoetic cells, i.e. leukemia cells. In preclinical studies a sensitization of mobilized leukemic cells to standard cytotoxic chemotherapy could be shown. Clinical studies are under way. CXCR4 antagonists are an exciting new class of compounds which are also employed for the mobilization of angiogenic cells or for the treatment of solid tumors. In this book a concise review of the current status of knowledge and future developments will be presented. From the Back Cover Recently, the CXCR4/CXCL12-axis has been recognized as one of the pivotal adhesion pathways by which hematopoietic stem cells are retained in the bone marrow. CXCR4 antagonists with different chemical specification are being developed. Pharmacology research guides the way to the rational development of effective antagonists. One antagonist, plerixafor, is now clinically approved for stem cell mobilization of lymphoma and myeloma patients. This progress allows patients to receive potentially life-saving treatment which could not have been administered otherwise. Through early clinical studies it was recognized that CXCR4 antagonists also mobilize malignant hematopoietic cells, i.e. leukemia cells. In preclinical studies, a sensitization of mobilized leukemic cells to standard cytotoxic chemotherapy could be shown.CXCR4 antagonists are an exciting new class of compounds which are also used for the mobilization of angiogenic cells or for the treatment of solid tumors. This book provides concise reviews of novel developments, as well as possible future developments on CXCR4.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 146141959X
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 15 February 2012
Listed Since: 07 September 2011

Barcode

No barcode data available

Springer Novel Developments in Stem Cell Mobilization: Focus on CXCR4

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)

Development and Approval of Combination Products: A Regulatory Perspective

Anticancer Genes: 818 (Advances in Experimental Medicine and Biology, 818)

Circulating Tumor Cells: Methods and Protocols: 1634 (Methods in Molecular Biology, 1634)

Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease

Concepts, Mechanisms, and New Targets for Chemotherapy: 78 (Cancer Treatment and Research, 78)

Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)

Chronic Myeloid Leukemia: Methods and Protocols: 1465 (Methods in Molecular Biology)

Critical Developments in Cancer Immunotherapy

Metastasis Research Protocols: 1070 (Methods in Molecular Biology, 1070)

Animal Models in Cancer Drug Discovery

Chemokine Receptors in Cancer (Cancer Drug Discovery and Development)

Radiation Oncology and Radiotherapy Part B (Volume 174) (Methods in Cell Biology, Volume 174)

The Bethesda Handbook of Clinical Oncology

Cancer Chemotherapy and Selective Drug Development: Proceedings of the 10th Anniversary Meeting of the Coordinating Committee for Human Tumour ... 24–28, 1983: 23 (Developments in Oncology)

Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)

Mathematical Oncology 2013 (Modeling and Simulation in Science, Engineering and Technology)

Cytotoxic Anticancer Drugs: Models and Concepts for Drug Discovery and Development: Proceedings of the Twenty-Second Annual Cancer Symposium Detroit, ... 1990: 68 (Developments in Oncology, 68)

Suicide Gene Therapy: Methods and Protocols: 1895 (Methods in Molecular Biology, 1895)

Immunotoxicity Testing: Methods and Protocols: 1803 (Methods in Molecular Biology, 1803)

Cutaneous Reactions from Anti-Cancer Therapies

Infection Management in Hematology (Hematologic Malignancies)

Electric Cell-Substrate Impedance Sensing and Cancer Metastasis: 17 (Cancer Metastasis - Biology and Treatment, 17)

The Chemistry of Antitumour Agents